We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMDPH
RNS Number : 0805F
Dechra Pharmaceuticals PLC
24 October 2018
24 October 2018
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on 22 October 2018, the following PDMRs exercised nil cost options over ordinary shares of 1p each in the Company. The options were granted to them on 15 September 2015 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP). The exercise of the options was subject to the achievement of performance conditions which were satisfied in full so that the options vested at 100%. The PDMRs sold sufficient shares (acquired pursuant to the exercise) in order to fund the resulting tax liability.
Hot Features
Premium
Name Capacity Options Shares Sold Sale Price Total beneficial Percentage
Exercised per share shareholding of issued
following this share capital
announcement
Ian Page Director 90,721 42,768 GBP21.395965 786,650 0.767%
Tony Griffin Director 22,641 11,355 GBP21.395965 75,606 0.074%
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Form
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
---------------------------------- ---------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------
a) Position/status Director/PDMR
---------------------------------- ---------------------------------------
b) Initial notification/ Initial Notification
amendment
---------------------------------- ---------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
---------------------------------- ---------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
---------------------------------- ---------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
---------------------------------- ---------------------------------------
b) Nature of the Exercise of 90,721 options under the
transaction Company's Long Term Incentive Plan
---------------------------------- ---------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBPNil Cost 90,721
---------------------------------- ---------------------- ---------------
d) Aggregated information
* Aggregate volume
N/A
* Price
---------------------------------- ---------------------------------------
e) Date of the transaction 2018.10.22
---------------------------------- ---------------------------------------
f) Place of the transaction Outside a trading venue
---------------------------------- ---------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
--------------------------------- ------------------------------------------
2. Reason for the notification
-----------------------------------------------------------------------------
a) Position/status Director/PDMR
--------------------------------- ------------------------------------------
b) Initial notification/ Initial Notification
amendment
--------------------------------- ------------------------------------------
3. Details of the Issuer
-----------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--------------------------------- ------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--------------------------------- ------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-----------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
--------------------------------- ------------------------------------------
b) Nature of the Partial sale of shares obtained under
transaction the Company's Long Term Incentive Plan
to satisfy tax liability
--------------------------------- ------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP21.395965 42,768
--------------------------------- ------------------------ ----------------
d) Aggregated information
* Aggregate volume 42,768
GBP915,062.63
* Price
--------------------------------- ------------------------------------------
e) Date of the transaction 2018.10.23
--------------------------------- ------------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------- ------------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Griffin
------------------------------------- ---------------------------------------
2. Reason for the notification
------------------------------------------------------------------------------
a) Position/status Director/PDMR
------------------------------------- ---------------------------------------
b) Initial notification/ Initial Notification
amendment
------------------------------------- ---------------------------------------
3. Details of the Issuer
------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
------------------------------------- ---------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
------------------------------------- ---------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
------------------------------------- ---------------------------------------
b) Nature of the Exercise of 22,641 options under the
transaction Company's Long Term Incentive Plan
------------------------------------- ---------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBPnil 22,641
------------------------------------- ------------------ -------------------
d) Aggregated information
* Aggregate volume
N/A
* Price
------------------------------------- ---------------------------------------
e) Date of the transaction 2018.10.22
------------------------------------- ---------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------- ---------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Griffin
--------------------------------- ------------------------------------------
2. Reason for the notification
-----------------------------------------------------------------------------
a) Position/status Director/PDMR
--------------------------------- ------------------------------------------
b) Initial notification/ Initial Notification
amendment
--------------------------------- ------------------------------------------
3. Details of the Issuer
-----------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
--------------------------------- ------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
--------------------------------- ------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-----------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
--------------------------------- ------------------------------------------
b) Nature of the Partial sale of shares obtained under
transaction the Company's Long Term Incentive Plan
to satisfy tax liability.
--------------------------------- ------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP21.395965 11,355
--------------------------------- ------------------------ ----------------
d) Aggregated information
* Aggregate volume 11,355
GBP242,951.18
* Price
--------------------------------- ------------------------------------------
e) Date of the transaction 2018.10.23
--------------------------------- ------------------------------------------
f) Place of the transaction London Stock Exchange
--------------------------------- ------------------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHFKQDDQBDDPKB
(END) Dow Jones Newswires
October 24, 2018 10:17 ET (14:17 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
